Profile DNA, RNA, protein, and phospho-protein targets up to 800-plex from a single sample. With curated content for specific research areas, including Immuno-Oncology, Solid Tumor, and Heme Profiling, get more data from less sample. Learn more about 3D Biology™ Technology | | | |
|
Bioentrepreneur | Top |
|
|
|
Data Page |
|
|
|
Top 20 translational researchers of 2016 p1126 Brady Huggett and Kathryn Paisner doi:10.1038/nbt.4028 |
|
Opinion and Comment | Top |
|
|
|
Correspondence |
|
|
|
The international MAQC Society launches to enhance reproducibility of high-throughput technologies pp1127 - 1128 Leming Shi, Rebecca Kusko, Russell D Wolfinger, Benjamin Haibe-Kains, Matthias Fischer et al. doi:10.1038/nbt.4029 |
|
|
|
Challenges and recommendations for epigenomics in precision health pp1128 - 1132 Ava C Carter, Howard Y Chang, George Church, Ashley Dombkowski, Joseph R Ecker et al. doi:10.1038/nbt.4030 |
|
Characterize the epitope landscape of your entire antibody library at the earliest stages of discovery to make smart decisions: - Maximize epitope diversity
- Identify unique epitopes
- Build your IP portfolio
Learn about the rapid assessment of an antibody library's epitopic diversity by reading this application note. Download the Application Note >> | | | |
|
|
Features | Top |
|
|
|
When pig organs will fly pp1133 - 1138 Emily Waltz doi:10.1038/nbt.4027 Regulators, scientists and surgeons are preparing the groundwork for human trials of engineered pig organs[mdash]and industry is starting to take notice. |
|
|
|
Patents |
|
|
|
Will inter partes review speed US generic drug entry? pp1139 - 1141 Jonathan J Darrow, Reed F Beall and Aaron S Kesselheim doi:10.1038/nbt.4036 A new extra-judicial pathway for challenging pharmaceutical patents has intensified patent challenges and helped to clear the way for earlier generic entry. |
|
|
|
Recent patents in xenotransplantation p1142 doi:10.1038/nbt.4040 |
|
News and Views | Top |
|
|
|
|
|
Research | Top |
|
|
|
Perspective |
|
|
|
Just how good an investment is the biopharmaceutical sector? pp1149 - 1157 Richard T Thakor, Nicholas Anaya, Yuwei Zhang, Christian Vilanilam, Kien Wei Siah et al. doi:10.1038/nbt.4023 An analysis of biotech and pharma stock prices since 1930 reveals sharp differences in the risk-adjusted returns of the two sectors. |
|
|
|
Review |
|
|
|
Microbial synthesis of medium-chain chemicals from renewables pp1158 - 1166 Stephen Sarria, Nicholas S Kruyer and Pamela Peralta-Yahya doi:10.1038/nbt.4022 Strategies to engineer microorganisms to produce medium-chain hydrocarbon chemicals are reviewed. |
|
|
|
Brief Communications |
|
|
|
Accurate assembly of transcripts through phase-preserving graph decomposition pp1167 - 1169 Mingfu Shao and Carl Kingsford doi:10.1038/nbt.4020 Scallop improves identification of multi-exon and transcripts expressed at low levels by retaining phasing information during assembly. |
|
|
|
Articles |
|
|
|
Highly accurate fluorogenic DNA sequencing with information theory-based error correction pp1170 - 1178 Zitian Chen, Wenxiong Zhou, Shuo Qiao, Li Kang, Haifeng Duan et al. doi:10.1038/nbt.3982 The error rate of DNA sequencing is much reduced by combining an improved fluorogenic sequencing chemistry with a new error-correction scheme. See also: News and Views by Sebra |
|
|
|
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing pp1179 - 1187 Hao Yin, Chun-Qing Song, Sneha Suresh, Qiongqiong Wu, Stephen Walsh et al. doi:10.1038/nbt.4005 Efficient Cas9 genome editing in vivo is achieved without viral vectors using chemically modified single-guide RNAs. |
|
|
|
Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro pp1188 - 1195 Thomas M Schmitt, David H Aggen, Kumiko Ishida-Tsubota, Sebastian Ochsenreither, David M Kranz et al. doi:10.1038/nbt.4004 The affinity of T cells for tumor self-antigens is improved by a culture system that identifies optimal T-cell-receptor B chains. See also: News and Views by Rappazzo & Birnbaum |
|
|
|
Letter |
|
|
|
Cell-type-specific metabolic labeling of nascent proteomes in vivo pp1196 - 1201 Beatriz Alvarez-Castelao, Christoph T Schanzenbacher, Cyril Hanus, Caspar Glock, Susanne tom Dieck et al. doi:10.1038/nbt.4016 Proteomes of distinct cell types in the brains of live mice are labeled and quantitated with a genetically encoded non-canonical amino-acid labeling method and click chemistry. |
|
|
|
Resources |
|
|
|
Three-dimensional map of nonhematopoietic bone and bone-marrow cells and molecules pp1202 - 1210 Daniel L Coutu, Konstantinos D Kokkaliaris, Leo Kunz and Timm Schroeder doi:10.1038/nbt.4006 A compendium detailing the localization of bone and bone-marrow-microenvironment cells and proteins will enable efforts to understand the functions of this niche. |
|
Careers and Recruitment | Top |
|
|
|
Institutional culture is the key to team science pp1212 - 1214 Sandra Soo-Jin Lee and Anna Jabloner doi:10.1038/nbt.4026 Institutional leadership in creating a culture of cooperation and pathways for multidisciplinary collaboration is critical to achieving the goals of academic translation and innovation. |
|
|
|
People |
|
|
|
People p1216 doi:10.1038/nbt.4041 |
|
Corrigenda | Top |
|
|
|
Corrigendum: In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis p1211 Jatin Roper, Tuomas Tammela, Naniye Malli Cetinbas, Adam Akkad, Ali Roghanian et al. doi:10.1038/nbt1217-1211a |
|
|
|
Corrigendum: Shotgun metagenomics, from sampling to analysis p1211 Christopher Quince, Alan W Walker, Jared T Simpson, Nicholas J Loman and Nicola Segata doi:10.1038/nbt1217-1211b |
|
|
|
Corrigendum: Development and function of human innate immune cells in a humanized mouse model p1211 Anthony Rongvaux, Tim Willinger, Jan Martinek, Till Strowig, Sofia V Gearty et al. doi:10.1038/nbt1217-1211c |
|
Erratum | Top |
|
|
|
Erratum: Revisiting the Warnock rule p1211 J Benjamin Hurlbut, Insoo Hyun, Aaron D Levine, Robin Lovell-Badge, Jeantine E Lunshof et al. doi:10.1038/nbt1217-1211d |
Advertisement |
|
|
|
|
| | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | |
|
No comments:
Post a Comment